Colonial Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Colonial Trust's REGN Position: Q2 2026 in Review
Colonial Trust increased its Regeneron Pharmaceuticals (REGN) stake by 3.6% in Q2 2026, buying an estimated $681 and bringing the position to 29 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #684.
Colonial Trust first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $24.4K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Colonial Trust held 29 shares of Regeneron Pharmaceuticals worth $18.3K as of Q2 2026.
- Colonial Trust bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
- Regeneron Pharmaceuticals made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #684 holding.
- Colonial Trust first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- Colonial Trust's Regeneron Pharmaceuticals position peaked at $24.4K in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.